A Case Study Integrative Occupational Therapy and Regenerative Care for Autism Spectrum Disorder (ASD)

A Case Study: Integrative Occupational Therapy and Regenerative Care for Autism Spectrum Disorder (ASD)

Case Overview

This case involves a 9-year-old pediatric client presenting with developmental, sensory-cognitive, and executive function considerations associated with Autism Spectrum Disorder (ASD). To support cognitive expansion, sensory processing, communication, and functional independence, an integrative care model was implemented combining structured Occupational Therapy (OT) with staged Umbilical Cord–derived Mesenchymal Stem Cell (UC-MSC) protocols and metabolic support.

The treatment strategy focuses on improving fine motor control, visual-perceptual skills, gross motor coordination, attention span, and social interaction within a safe, multidisciplinary clinical framework.

Baseline Presentation and Assessment

Clinical & Behavioral Observations

Upon clinical evaluation, the client demonstrated high engagement and motivation, responding exceptionally well to visual cues and gesture prompts. While basic arousal levels and general physical health were well-maintained, key developmental targets were identified:

• Attention & Executive Function: Low continuous attention span (baseline: 4–5 minutes).

• Fine Motor & Visual-Perceptual Skills: Emerging line-cutting accuracy, letter size/spacing consistency during handwriting, and complex pattern execution.

• Social Communication & Motor Planning: Emerging turn-taking skills during structured games and obstacle motor planning.

Assessment Summary (ATEC Baseline)

• Assessment Date: July 2026

• Total ATEC Score: 58 / 179 (Mild-to-Moderate Range)

• Key Observations: Strong foundational balance and color discrimination, with primary focus areas centered on communication continuity, executive attention, and social turn-taking.

Integrated Treatment Plan & Care Sequence

The client’s management plan integrates structured developmental therapy with a two-phase regenerative care program designed to modulate systemic inflammation, support neuro-plasticity, and enhance cellular metabolism.

Here is the summary table of the two-phase treatment plan in English:

A. Occupational Therapy & Behavioral Framework

• Executive Function: Progressive expansion of sustained attention target from 4–5 minutes to 10 minutes.

• Fine Motor & Handwriting: Precision exercises for pencil grip, letter spacing, line cutting, and pattern replication.

• Motor Planning & Balance: Dynamic balance routines and obstacle clearance coordination.

• Home Program Integration: Daily 5–10 minute structured motor exercises, 2-choice vocabulary discrimination, and family turn-taking games.

Staged Regenerative Care Program (UC-MSC Protocols)

Phase 1: Initial Protocol (August – September 2025)

• Total Volume: 70 million MSCs (divided into two intravenous infusions of 35M MSCs with growth factors).

• Supportive Interventions: Comprehensive blood panels, Vega Brain Booster IV drips, growth factor support, occupational therapy sessions, and medical consultations.

• Objective: Establish baseline immune balance, reduce systemic inflammatory cytokines, and support metabolic energy.

Phase 2 : Advanced Consolidation Protocol (July 2026)

• Total Volume: 80 million MSCs delivered across a multi-route protocol:

• Intravenous (IV) Infusions: 60 million MSCs total (administered in two 30M sessions).

• Intrathecal (IT) Injection: 20 million MSCs delivered under fluoroscopic guidance in a hospital setting for direct central nervous system signaling support.

• Supportive Interventions: Comprehensive blood work, Vega Brain Booster IV infusions, clinical OT integration, and post-treatment medical consultations.

• Objective: Enhance central neural signaling, support synaptic connectivity, and consolidate cognitive and motor gains.

Observed Outcomes & Recommended Follow-Up

Clinical Progress

• High Engagement: Active participation and positive responsiveness to visual and gesture prompts.

• Perceptual Strengths: Independent color sorting, 5-color pattern threading, and receptive vocabulary discrimination.

• Motor Control Improvements: Noticeable gains in static/dynamic balance and age-appropriate pencil grip control.

Long-Term Tracking Metrics

• Continuous attention duration during unprompted visual tasks (target: 10 minutes).

• Handwriting legibility, spacing, and cutting line precision.

• Social turn-taking compliance during structured group activities.

• Serial ATEC score monitoring at 6 and 12 months post-protocol.

Physician’s Perspective & Clinical Conclusion

From an integrative neurodevelopmental perspective, combining structured Occupational Therapy with targeted cellular signaling protocols offers a comprehensive approach to managing Autism Spectrum Disorder.

While Occupational Therapy builds essential behavioral, motor, and cognitive pathways, systemic and intrathecal UC-MSC applications aim to optimize the biological environment by reducing neuroinflammation, supporting microvascular perfusion, and encouraging synaptic plasticity.

Executing cellular care across planned, multi-route phases complemented by metabolic IV support and continuous developmental tracking provides a safe and structured framework to help pediatric clients achieve greater cognitive stability, functional independence, and overall quality of life.